Search Result |
Top |
Entry | Name | Formula | Mass |
---|---|---|---|
C10759 |
6-Pentadecylsalicylic acid Anacardic acid |
C22H36O3 | 348.2664 |
C19725 |
UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate UDP-alpha-D-GlcNAc3NAcA UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid |
C19H28N4O18P2 | 662.0874 |
C19745 |
UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate UDP-alpha-D-ManNAc3NAcA UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronic acid |
C19H28N4O18P2 | 662.0874 |
C20395 |
UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate UDP-3-keto-GlcNAcA |
C17H23N3O18P2 | 619.0452 |
C20497 |
N-Acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol Und-PP-GlcNAc-ManNAcA Lipid II |
C71H116N2O18P2 | 1346.7698 |
C20498 |
4-Acetamido-4,6-dideoxy-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol Und-PP-GlcNAc-ManNAcA-Fuc4NAc Lipid III |
C79H129N3O22P2 | 1533.8543 |
C21213 |
Archaeal dolichyl 3-O-(2,3-diacetamido-2,3-dideoxy-beta-D-glucuronsyl)-N-acetyl-alpha-D-glucosaminyl phosphate Dol-P-GlcNAc-Glc-2,3-diNAcA |
C38H66N3O15P(C5H8)n | |
C22245 |
UDP-2-acetamido-2-deoxy-alpha-D-galacturonamide UDP-GalNAcAN |
C17H26N4O17P2 | 620.0768 |
C22576 |
UDP-2-acetamido-2-deoxy-L-altruronic acid UDP-L-AltNAcA |
C17H25N3O18P2 | 621.0608 |
C22695 |
N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide APINACA N-(5-fluoropentyl) 5F-APINACA |
C23H30FN3O | 383.2373 |
C22698 |
ADB-CHMINACA N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-cyclohexylmethyl-1H-indazole-3-carboxamide |
C21H30N4O2 | 370.2369 |
C22699 |
ADB-FUBINACA N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide |
C21H23FN4O2 | 382.1805 |
C22702 |
AB-CHMINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-cyclohexylmethyl-1H-indazole-3-carboxamide |
C20H28N4O2 | 356.2212 |
C22703 |
AB-FUBINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide |
C20H21FN4O2 | 368.1649 |
C22704 |
AB-PINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide |
C18H26N4O2 | 330.2056 |
C22722 |
Cumyl-4CN-BINACA 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide 4-Cyano Cumyl-BUTINACA SGT-78 |
C22H24N4O | 360.195 |
C22788 |
MDMB-4EN-PINACA Methyl (2S)-3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
C20H27N3O3 | 357.2052 |
C22799 |
4F-MDMB-BINACA Methyl (2S)-2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate |
C19H26FN3O3 | 363.1958 |
C22800 |
AMB-FUBINACA Methyl (2S)-2-[1-(4-fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoate FUB-AMB MMB-FUBINACA |
C21H22FN3O3 | 383.1645 |
C22801 |
5F-MDMB-PINACA Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate |
C20H28FN3O3 | 377.2115 |
C22818 |
ADB-BUTINACA N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butylindazole-3-carboxamide N-(1-Amino-3,3-dimethy-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide |
C18H26N4O2 | 330.2056 |
[ KEGG | DISEASE | DRUG | MEDICUS ] |